GSE114016
Gene expression analysis of prostate cancer cells treated with fatty acid synthase (FASN) inhibitor IPI-9119
Alterations in gene expression following fatty acid synthase inhibtion were evaluated in androgen sensitive LNCaP cells and castration resistant 22Rv1 and LNCaP-95 cells.  Cell were exposed to 2 concentrations (0.1 and 0.5 uM) of  FASN inhibitor IPI-9119 or DMSO for 6 days. Overall design: Differential gene expression anlaysis in 3  prostate cancer cell lines treated with FASN inhibitor IPI-9119